Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-10 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-10 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo pharmacokinetic and in vivo pharmacodynamic properties, and better hepatic microsomal stability. Cap-dependent endonuclease-IN-10 has the potential for the research of viral infections (including influenza A, influenza B and influenza C) (extracted from patent WO2021129799A1, compound 1-1)[1].
Web ID
– HY-143757
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C25H18F2N4O5S
References
– [1]Yingjun Zhang, et al. Influenza virus replication inhibitors and their uses. Patent WO2021129799A1.
CAS Number
– 2663989-04-4
Molecular Weight
– 524.50
SMILES
– FC1=C2C([C@@](N3N4C(C(N5[C@@]3([H])COCC5)=O)=C(C(C=C4)=O)O)([H])C6=CC=CC7=C6N(C(S7)=O)C2)=CC=C1F
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
